Introduction. Multiple sclerosis (MS) is a major cause of disability among young people after traumatic injuries. Many studies indicate changes in the clinical picture of MS over time, which is partly attributed to the use of pathogenetic therapy. Aim. To study the changes in the clinical picture of MS between 01.01.2003 and 31.12.2022 in Novosibirsk. Materials and methods. 1783 patients with MS diagnosed in the period from 01.01.2003 to 31.12.2022, who lived in Novosibirsk, were included in the study. The clinical picture was described (symptoms grouped by functional systems of the Kurtzke Expanded Disability Status Scale (EDSS)); besides, the MS phenotype, EEDSS score, and whether MS disease-modifying therapies (MSDMTs) were prescribed indicating their duration, were determined. The number of symptoms at the onset (mono- and polysymptomatic) and the grade of recovery of neurological disorders were assessed. The achievement of EDSS 3,0 and EDSS 6,0 in the group of “controlled” MS was also analyzed, considering the following indices: duration of the disease (time from the onset of the clinical phase of MS to 12.31.2022), the interval “onset – EDSS 3,0”, the interval “onset – EDSS 6,0”. This group included 1494 patients who met two criteria: MSDMTs for at least 6 months, and the duration of the MS clinical phase for at least 2 years. Results. Pathogenetic therapy of MS changed the course of the disease. The clinical picture of MS was characterized by an increase in the proportion of patients with a remitting course (from 52 to 75%, p < 0,05). The role of the gender of patients in achieving permanent disability has decreased. The onset symptoms were found to be of great importance in the long-term prognosis of persistent disability (p < 0,05). Conclusion. Gender, age, symptoms at the MS onset, and the use of pathogenetic therapy correlate with the risk and likelihood of achieving permanent disability (p < 0,05).